863 top medical experts on Pheochromocytoma across 49 countries and 33 U.S. states, including 807 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Pheochromocytoma: A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the adrenal medulla or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of epinephrine and norepinephrine, is hypertension, which may be persistent or intermittent. During severe attacks, there may be headache; sweating, palpitation, apprehension, tremor; pallor or flushing of the face, nausea and vomiting, pain in the chest and abdomen, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Paraganglioma (1,305).
  4. Clinical Trials ClinicalTrials.gov : at least 70 including 6 Active, 23 Completed, 24 Recruiting
  5. Synonyms: Extra-Adrenal Pheochromocytoma


  

        

                    


    Computing Expert Listing ...

);